ReviewCureus2025

Evaluating the Beneficial Effect of Empagliflozin in Reducing Hospitalisation for Heart Failure in Patients With Type 2 Diabetes Mellitus: A Systematic Review.

Akanksha Soni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.